# UBS

Type: Company (UBS)

Source: Finance Intelligence Brief — https://getfinancebrief.com/entity/ubs
Canonical HTML page: https://getfinancebrief.com/entity/ubs

## Recent coverage (5 stories)

### UBS Slashes Campbell's Price Target to $20 Amid Volume Growth Concerns
2026-03-25 16:54:21 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

UBS has significantly lowered its price target for The Campbell's Company (CPB) from $24 to $20, signaling deep caution over the food giant's growth trajectory. The move reflects broader sector headwinds as packaged food companies struggle to balance price hikes with declining consumer volume.
Full story: https://getfinancebrief.com/story/ubs-cuts-campbell-company-price-target-analysis

### Goldman Sachs Reaffirms $250 Nvidia Target as GTC Boosts AI Confidence
2026-03-23 00:20:09 · Sentiment: Bullish · Impact: 7/10 · Sources: 3

Goldman Sachs has reiterated its bullish $250 price target for Nvidia following the GTC 2026 conference, dismissing bearish concerns about slowing AI demand. Analysts cite increased visibility into hyperscaler spending and the strength of the Blackwell architecture as primary drivers for continued market dominance.
Full story: https://getfinancebrief.com/story/goldman-sachs-nvidia-gtc-analysis-2026

### US Lawmakers Sound Alarm Over Chinese Dominance in Pharmaceutical Supply Chain
2026-03-19 00:22:06 · Sentiment: Bearish · Impact: 8/10 · Sources: 3

The House Select Committee on China has warned that Beijing is executing a strategic 'playbook' to dominate the global pharmaceutical market, mirroring its previous successes in rare earths and electric vehicles. With Chinese medical revenue projected to reach $2.1 trillion by 2030, US officials are weighing the national security risks of a supply chain heavily dependent on Chinese-made active pharmaceutical ingredients.
Full story: https://getfinancebrief.com/story/us-china-pharmaceutical-supply-chain-dependence

### UBS Sets $245 Nvidia Target as $100B Quarterly Revenue Becomes Reality
2026-03-06 00:26:17 · Sentiment: Bullish · Impact: 8/10 · Sources: 2

UBS has reiterated a strong Buy rating on Nvidia with a $245 price target following a record-breaking fiscal fourth quarter and massive forward guidance. The firm's bullishness stems from accelerating data center demand and the arrival of the 'agentic AI' era, which is driving inventory commitments to unprecedented levels.
Full story: https://getfinancebrief.com/story/ubs-nvidia-stock-price-target-analysis

### UBS Trims Brookfield Asset Management Target to $52 Amid Neutral Outlook
2026-02-26 14:31:15 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

UBS has revised its price target for Brookfield Asset Management (BAM) downward to $52 while maintaining a Neutral rating. The adjustment reflects a cautious stance on the alternative asset manager's valuation and growth trajectory in a shifting global interest rate environment.
Full story: https://getfinancebrief.com/story/ubs-lowers-brookfield-bam-price-target-neutral-rating

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getfinancebrief.com/guides/methodology for the full editorial methodology.